device (1)

World’s First InterAtrial Shunt Designed to Treat Heart Failure.

Corvia Medical, Inc., is dedicated to revolutionizing the treatment of heart failure with first-in-class structural heart devices. The company has developed the world’s first transcatheter device designed to treat heart failure with preserved (HFpEF) or mid-range (HFmrEF), ejection fraction, previously known as diastolic heart failure (DHF). The innovative InterAtrial Shunt Device (IASD®) is designed to reduce elevated left atrial pressure (LAp), which is the main cause of heart failure symptoms.


Clinical Study Information

Corvia Medical recently completed enrollment in the REDUCE LAP HF I study. To learn more, visit


Hear From Our Sites

Patients Eager to Test Device That Could Ease Heart Failure Symptoms

Ohio State Evaluates First Transcatheter Implant for Diastolic Heart Failure